Inhibition of pancreatic lipase

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9402858
APP PUB NO 20120302521A1
SERIAL NO

13512118

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides the use of an alginate Io inhibit pancreatic lipase. The use may be directed to the control of weight in animals including human beings. Preferably the fraction of guluronate dimers in the alginate is at least 0.5.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF NEWCASTLE UPON TYNEKINGS GATE NEWCASTLE UPON TYNE NE1 7RU
RD BIOMED LIMITEDHULL HU1 4BG

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Brownlee, Iain Andrew Singapore, SG 2 0
Dettmar, Peter William East Yorkshire, GB 16 309
Pearson, Jeffrey Peter Consett, GB 3 3
Richardson, Johnathan Craig Notts, GB 6 96
Wilcox, Matthew David Newcastle upon Tyne, GB 3 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 2, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00